UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000003751
Receipt number R000004546
Scientific Title A phase II feasibility trial of Gemcitabine Hydrochloride and Krestin combination therapy in pancreatic cancer after surgery.
Date of disclosure of the study information 2010/06/30
Last modified on 2010/06/14 19:13:09

No. Disposal Last modified on Item of update
1 Insert 2010/06/14 19:13:44